glp-1 pregnancy category use during early may not increase risk of major adverse outcomes Understanding GLP-1 Medications and Pregnancy

This limitation arises from the inclusion of the concept of drug notoriety, which assigns higher scores to agents with well-established associations, such as sulfonamides.3 CAIs are considered drugs with unknown associated risk despite sharing many structural similarities with sulfonamides

Listen to this episode of Longevity by Design on Apple Podcasts, Spotify, and YouTube

It is worth walking through what those trials actually measured

However, a larger randomized controlled trial in patients with type 2 diabetes at the same dose didnt find significant changes in insulin sensitivity or glycemic control

The primary goal is to maximize the natural nocturnal GH pulse

2d), GLP-1RA monotherapy (RR = 0.37, 95% CI 0.22